pharmacology ii cardiac & vascular

29
Pharmacology II Cardiac & Vascular Kathy Plitnick RN PhD CCRN Georgia Baptist College of Nursing

Upload: saddam

Post on 11-Jan-2016

47 views

Category:

Documents


2 download

DESCRIPTION

Pharmacology II Cardiac & Vascular. Kathy Plitnick RN PhD CCRN Georgia Baptist College of Nursing. Physiology of Circulation. Return of deoxygenated blood to the heart Enters the lungs to reoxygenated Ejected out of the left ventricle. Cardiac Glycosides. Positive Inotropes - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Pharmacology II           Cardiac & Vascular

Pharmacology II Cardiac & VascularKathy Plitnick RN PhD CCRN

Georgia Baptist College of Nursing

Page 2: Pharmacology II           Cardiac & Vascular

Physiology of Circulation

Return of deoxygenated blood to the heart Enters the lungs to reoxygenated Ejected out of the left ventricle

Page 3: Pharmacology II           Cardiac & Vascular

Cardiac Glycosides

Positive Inotropes Increase contractility & CO Improved renal perfusion

Increased GFR Increased urine output

Slow onset of action

Page 4: Pharmacology II           Cardiac & Vascular

Digoxin – Prototype

Inhibits Na/K+ pump Calcium remains intracellular longer Improves contractility Lowers heart rate Treatment for At. Fib/Flutter, PSVT Digitalization

Page 5: Pharmacology II           Cardiac & Vascular

Digoxin – Prototype

Side Effects Bradycardia Heart block

Toxic Effects CNS & GI Visual disturbances Precipitated by low K+, Mg, & Ca+ levels Antidote: Digibind

Therapeutic Level: 0.5-2.0 ng/ml

Page 6: Pharmacology II           Cardiac & Vascular

Digoxin – Prototype

NursingAssess apical pulse for 60 secondsHold if HR < 60, Call MDDraw blood levels 6-8 hours after doseMonitor drug levels, electrolytesTeach patient to take own pulseMonitor K+, Mag & Calcium

Page 7: Pharmacology II           Cardiac & Vascular

Cardiotonics

Inocor – Inamrinone Primacor – Milrinone

Both given by continuous IV infusionDosages adjusted to maintain a CI > 2.0Heart Transplant candidates

Page 8: Pharmacology II           Cardiac & Vascular

Coronary Vasodilators

Nitrates: Nitroglycerin, IsordilRelax arterial & venous smooth musclePrimary effect on veinsDecrease myocardial work, O2 requirements

Improves perfusion during ischemiaArterial dilatation

Page 9: Pharmacology II           Cardiac & Vascular

Nitrates

RoutesSublingualOralOintmentTransdermalParenteral

Page 10: Pharmacology II           Cardiac & Vascular

Nitrates

Side EffectsHeadache HypotensionDizzinessPalpitationsDifficulty breathingChest pain

Page 11: Pharmacology II           Cardiac & Vascular

Nitrates

Nursing IV infusion – frequent VS

Continuous cardiac monitoring

Maintain systolic BP > 90 mmHgSublingual

3 tablets q 5 minutes Call 911 if no relief

Continuous cardiac monitoring

Page 12: Pharmacology II           Cardiac & Vascular

Antidysrhythmic Agents

Terminate/prevent abnormal cardiac rhythms

Classified according to primary effect on action potential

Page 13: Pharmacology II           Cardiac & Vascular

Class I – Sodium Channel Blockers

Decrease influx of Na+ ions through fast channels during phase 0

Prolongs absolute refractory period Slow rate of spontaneous depolarization

during phase 4 Negative inotrope, chronotrope Decrease myocardial O2 demand

Page 14: Pharmacology II           Cardiac & Vascular

Class IA – Quinidine

Also slows phase 3 repolarizationProlong AP duration Increases QRS & QT

Depress contractility Give with food Cardiac monitoring

Page 15: Pharmacology II           Cardiac & Vascular

Class IB – Lidocaine

Continuous IV for ventricular dysrhythmias Weakens phase 4 Decreases automaticity, AP duration Raises V. Fib threshold Biphasic half-life Topical & local anesthetic Lidocaine “crazies”

Page 16: Pharmacology II           Cardiac & Vascular

Class IC – Encainide, Flecainide, Propafenone Slow conduction through His-Purkinje Increase both PR & QRS Increased mortality with Encainide &

Flecainide

Page 17: Pharmacology II           Cardiac & Vascular

Class II – Beta Blockers

CardioselectiveMetoprololAtenololAcebutolol

Non-cardioselectivePropranolol – PrototypeNadololEsmolol

Page 18: Pharmacology II           Cardiac & Vascular

Class III - Amiodarone

Slow rate of phase 3 repolarization Increase effective refractory period Treat atrial & ventricular dysrhythmias Has characteristics of all 4 classes Blocks potassium channels Vasodilatory action

Page 19: Pharmacology II           Cardiac & Vascular

Amiodarone

Major Adverse EffectsHypotension, bradycardia, AV blockElevation of LFT’sProarrhythmic effectTorsades ARDSPulmonary fibrosis

Page 20: Pharmacology II           Cardiac & Vascular

Amiodarone

NursingBaseline pulmonary, LFT’s, CXRMonitor VS, EKGAssess pulse for strength, rate, regularityMonitor for side effects

Nausea, fever, decreased appetite Blue-gray discoloration of skin Blurred vision

Page 21: Pharmacology II           Cardiac & Vascular

Amiodarone

Correct electrolyte imbalances Check SaO2/ABG’s Continuous cardiac monitoring

Central line for infusion

Page 22: Pharmacology II           Cardiac & Vascular

Class IV – Calcium Channel Blockers Inhibit influx of calcium during phase 2 Primarily in sinus & AV nodes, atrial tissue Negative inotropic, chronotropic,

dromotropic effects Increases angina threshold

Page 23: Pharmacology II           Cardiac & Vascular

Verapamil (Calan)

Depresses sinus & AV node Terminates SVT caused by AV nodal

reentry Controls ventricular rate in AFib/Flutter Contraindicated in Sick Sinus Syndrome,

advanced block, cardiogenic shock

Page 24: Pharmacology II           Cardiac & Vascular

Verapamil

NursingAdminister slow > 2 minutesContinuous EKG monitoringFrequency VSAvoid concomitant use of Beta Blockers

Page 25: Pharmacology II           Cardiac & Vascular

Diltiazem (Cardizem)

Fewer hypotensive side effects Control of ventricular rate in atrial

dysrhythmias Rapid conversion of PSVT to NSR Treatment of Angina Initial bolus followed by continuous IV

Page 26: Pharmacology II           Cardiac & Vascular

Adenosine

Treatment of PSVT & diagnostic aid Slows impulse formation in SA node & through

AV node Depresses LV function Half-life less than 10 seconds ! Monitor patient very closely Given IV bolus Monitor EKG, apical pulse, BP, respirations

Page 27: Pharmacology II           Cardiac & Vascular

Antihyperlipidemics

Definition of Hyperlipidemia Can lipids be bad? 3 Types of Agents Used

HMG CoA reductase inhibitors - Statins Zocor, Mevacor, Pravachol Block the synthesis of cholesterol in the liver Decrease LDL, increase HDL

Fibric Acids Lopid, Tricor Decrease concentration of VLDL Increase lipase – promotes VLDL catabolism

Page 28: Pharmacology II           Cardiac & Vascular

Antihyperlipidemics

Bile Acid SequestrantsQuestran, Welchol, ColestidLower LDL levelsBind bile acids in intestine

Major Interaction Increase effects of anticoagulantsDo not give with grapefruit juice

Page 29: Pharmacology II           Cardiac & Vascular

Antihyperlipidemics

Dietary corrections Reduce fats, sugars & cholesterol High fiber foods Obtain baseline levels Monitor GI effects Increase water intake Administer dose in evenings